Bioorganic and Medicinal Chemistry Letters p. 2586 - 2590 (2010)
Update date:2022-08-05
Topics:
Bursavich, Matthew G.
Brooijmans, Natasja
Feldberg, Lawrence
Hollander, Irwin
Kim, Stephen
Lombardi, Sabrina
Park, Kaapjoo
Mallon, Robert
Gilbert, Adam M.
A series of benzofuran-3-one indole phosphatidylinositol-3-kinases (PI3K) inhibitors identified via HTS has been prepared. The optimized inhibitors possess single digit nanomolar activity against p110α (PI3K-α), good pharmaceutical properties, selectivity versus p110γ (PI3K-γ), and tunable selectivity versus the mammalian target of rapamycin (mTOR). Modeling of compounds 9 and 32 in homology models of PI3K-α and mTOR supports the proposed rationale for selectivity. Compounds show activity in multiple cellular proliferation assays with signaling through the PI3K pathway confirmed via phospho-Akt inhibition in PC-3 cells.
View MoreShanghai Potomer International Trade CO., LTD
Contact:+86-21-61397128
Address:Room 304,No.505 ,Caoyang Road.Shanghai,China
Contact:0086-27-83607103/83642615
Address:No.498, Jianshe Ave, Wuhan, China
AllyChem Co., Ltd., Dalian, China(BBChem)
Contact:+86-411-62313318/62313328
Address:No.5 of Jinbin Road, Jinzhou New District, Dalian City, Liaoning Province, P.R.China
WUXI KINGHAN BIO-MEDICAL&CHEMICAL INC.
Contact:13861062998
Address:Room 1316,No.1619 Huishan Avenue,Wuxi,China
Contact:+86-512-69561895
Address:No.111, Building A4, 218 Xinghu Street, Suzhou Industrial Park, P. R. China
Doi:10.1016/j.tetlet.2009.09.108
(2009)Doi:10.1007/BF00869032
()Doi:10.1021/jm00295a028
(1970)Doi:10.1039/J29710001142
(1971)Doi:10.1023/B:RUCO.0000047465.70746.fd
(2004)Doi:10.1002/1522-2675(20010131)84:1<163::AID-HLCA163>3.0.CO;2-B
(2001)